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Abstract Quality assurance (QA) guidelines are essential
to provide uniform execution of clinical trials with uniform
quality hyperthermia treatments. This document outlines
the requirements for appropriate QA of all current superfi-
cial heating equipment including electromagnetic (radiative
and capacitive), ultrasound, and infrared heating techniques.
Detailed instructions are provided how to characterize and
document the performance of these hyperthermia applica-
tors in order to apply reproducible hyperthermia treatments
of uniform high quality. Earlier documents used specific
absorption rate (SAR) to define and characterize applica-
tor performance. In these QA guidelines, temperature rise
is the leading parameter for characterization of applicator
performance. The intention of this approach is that charac-
terization can be achieved with affordable equipment and
easy-to-implement procedures. These characteristics are es-
sential to establish for each individual applicator the spe-
cific maximum size and depth of tumors that can be heated
adequately. The guidelines in this document are supple-
mented with a second set of guidelines focusing on the clin-
ical application. Both sets of guidelines were developed by
the European Society for Hyperthermic Oncology (ESHO)
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Leitlinien zur Qualitätssicherung der lokalen
Hyperthermie in klinischen Studien
II. Technische Anforderungen an Heizgeräte
Zusammenfassung Um eine einheitliche Durchführung
klinischer Studien in der Hyperthermie zu gewährleisten,
sind Leitlinien zur Qualitätssicherung (QA) unerlässlich.
Dieses Dokument enthält die Anforderungen zur QA für
alle aktuellen Therapiegeräte zur lokalen Hyperthermie, in-
klusive elektromagnetischer Systeme (radiativ und kapazi-
tiv), Ultraschall- und Infrarottechnik. In detaillierten An-
leitungen wird erklärt, wie die Leistungscharakteristik der
Hyperthermieapplikatoren zu beschreiben und zu dokumen-
tieren ist, um reproduzierbare, einheitliche und qualitativ
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hochwertige Hyperthermiebehandlungen zu gewährleisten.
Im Gegensatz zu früheren Leitlinien wird anstelle der spezi-
fischen Absorptionsrate (SAR) jetzt der Temperaturanstieg
als maßgeblicher Parameter für die Beschreibung der Leis-
tungscharakteristik von Hyperthermieapplikatoren verwen-
det. Grund für diesen Ansatz ist eine möglichst einfache und
kostengünstige Leistungsbeschreibung. Diese ist notwen-
dig, um für jeden einzelnen Applikator die maximale Tu-
morgröße und -tiefe zu bestimmen, die adäquat überwärmt
werden kann. Dieses Dokument wird durch die Leitlinie zur
klinischen Durchführung der lokalen Hyperthermie vervoll-
ständigt. Beide Teile der Leitlinie wurden vom Technischen
Komitee der European Society for Hyperthermic Oncology
(ESHO) in Zusammenarbeit mit leitenden Mitgliedern der
Society of Thermal Medicine (STM) und Mitgliedern des
Atzelsberger Kreises erarbeitet.
Schlüsselwörter Qualitätssicherung · Hyperthermie,
lokale · Applikator · Wasserbolus · Phantome ·
Heizkriterien
Introduction
These quality assurance (QA) guidelines for the application
of superficial hyperthermia clinical trials were developed at
the request of the Atzelsberg Circle for Clinical Hyperther-
mia of the interdisciplinary working group of hyperther-
mia “Interdisziplinäre Arbeitsgruppe Hyperthermie” (IAH)
[1] of the German Cancer Society (“Deutsche Krebsge-
sellschaft”) to the European Society for Hyperthermic On-
cology (ESHO) [2]. ESHO delegated this task to the ESHO
technical committee (TC), who formulated the guidelines
with participation of experienced members of the Society
for Thermal Medicine (STM) [3]. In addition, the manu-
facturers providing equipment for superficial hyperthermia
were invited to provide their feedback on the QA guidelines
during public sessions at the 2014 and 2015 annual meet-
ings of ESHO or alternatively by personal communication.
The QA guidelines seek to establish a minimum level
of treatment quality in hyperthermia treatments delivered
in all multi-institutional studies initiated by the Atzelsberg
Circle or under the auspices of the ESHO. The goal of
this effort is to establish QA guidelines for the application
of superficial hyperthermia, similar to the QA guidelines
for administration of deep hyperthermia defined earlier [4,
5] and as a long awaited follow up to previous superfi-
cial hyperthermia QA guidelines provided by the Radiation
Therapy Oncology Group and ESHO [6–8].
These QA guidelines for the application of superficial
hyperthermia clinical trials consists of two parts:
● Part I [9] provides detailed instructions on treatment doc-
umentation, defines a good hyperthermia treatment, and
identifies the clinical conditions where a certain hyper-
thermia system can or cannot adequately heat the tumor
volume.
● Part II, i. e., this document, provides quality assurance
requirements for heating equipment as well as detailed
instructions how to characterize and document the per-
formance of hyperthermia devices in order to apply re-
producible, uniform, and high quality hyperthermia treat-
ments. These characteristics help to establish the maxi-
mum size and depth of tumors that can be heated ade-
quately.
Implementation of these QA guidelines should facilitate
correct assessment of whether a tumor can or cannot be
heated with the specific heating device(s) available in a hy-
perthermia center and, thus, enable a decision as to whether
a patient is or is not eligible to participate in a clinical study.
Many different systems are used to apply superficial hy-
perthermia, either built commercially or in academic re-
search laboratories. Each system has unique characteristics
and advantages (as summarized in Appendix A), which may
result in a large heterogeneity in the quality of applied hy-
perthermia treatments between various hyperthermia cen-
ters.
To assure proper performance of a superficial hyper-
thermia applicator, the spatial thermal pattern should be
evaluated under well-controlled conditions prior to the first
clinical use of the applicator and at regular intervals as
part of a clinical QA program. Due to time constraints in
the clinical workflow and the large diversity of superficial
heating systems, which include electromagnetic (EM), ra-
diofrequency (RF), ultrasound (US), and infrared (IR) tech-
nologies, these new QA guidelines require characterization
of the heating performance of hyperthermia equipment with
temperature (rise) simulations and measurements in homo-
geneous muscle tissue-equivalent phantoms. This is a more
pragmatic approach than that used in previous guidelines/
recommendations, which were based on power deposition
patterns quantified in W/kg and described as Specific Ab-
sorption Rate (SAR) distributions. For homogenous non-
perfused phantom models, the SAR and temperature rise
in a defined period of time are directly related, since no
convective heat losses are present [10].
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Definitions and characteristic features
of a superficial hyperthermia system
Applicators
Superficial applicators, used today, consist of
● External EM antennas or waveguides,
● External EM capacitive electrodes (“capacitive” RF sys-
tems),
● External US transducers (US systems), and
● External noncontacting IR heating systems.
In general, these devices deposit energy to heat a lim-
ited volume of tissue close to the heating device. A brief
summary of the operating principles of various systems for
heating superficial tissue is given in Part I of the QA guide-
lines [9], while more detailed equipment options are given
in Appendix A. Further information can be found in reviews
[11–14].
Superficial hyperthermia applicator terminology
● Single applicator: A single radiating aperture connected
to a power amplifier having independent control of out-
put power from 0–100%. The applicator can be an EM
radiator [16–24], US transducer [14], IR lamp [15], or
the active electrode of a capacitive system [52, 53].
● Multi-element applicator array: To produce effective
heating of large area tumors, several single applicators
can be combined into larger arrays with separate power
control of each element to enable 2D power steering [25,
29, 34, 36]. Examples include patient-customized arrays
of separately placed applicators such as 2–6 lucite cone
applicator (LCA) [18] or two adjacent contact flexible
microstrip applicator (CFMA) [19].
● Multi-element array applicator: Alternatively a heat ap-
plicator can be constructed with a fixed spatial array of
independently controlled heating elements, such as spiral
microstrip [26–28], conformal microwave array (CMA)
[30–33], Microtherm 1000 planar array [35] applicators,
or a fixed array of ultrasound apertures, such as four and
sixteen element devices [60, 61].
In order to generate sufficiently uniform and repeatable
heating, special care must be devoted to interapplicator
spacing and noncoherent phase excitation in order to mini-
mize cross-coupling and phase interaction between adjacent
applicators and to achieve a contiguous SAR/temperature
distribution above the 50% iso-SAR or 50% isotemperature
level across the tissue target between applicator elements.
Single applicators and multi-element applicators should
fulfill the following criteria or be characterized as follows:
● Every single radiating aperture should be capable of pro-
ducing effective superficial HT under the aperture (Sec-
tion Test conditions).
● Every radiating element of an applicator array or array
applicator must be powered noncoherently in order to
avoid cross-coupling effects between the elements.
● Multiple coherently radiating elements may be consid-
ered as a single independent radiating element if a com-
mon wave front is created parallel to the surface.
● The therapeutic region of an array applicator or an ap-
plicator array is defined analogously to the definition of
therapeutic region for a single applicator.
It is strongly recommended to include thermometry mea-
surement points underneath each independently powered
element of an array applicator or applicator array.
Technical considerations for the water bolus
The function of the temperature-controlled water-circulat-
ing bolus is to couple electromagnetic or ultrasound energy
into the patient and to control the skin surface temperature.
IR systems generally operate without a water bolus and can
achieve some control of skin surface temperatures through
forced convection of air.
General requirements for the water bolus
An optimal contact area of the water bolus with the skin of
the target surface requires that the bolus is sufficiently large
to smoothly follow the skin contour [37–40] and that the
bolus extends beyond the radiating aperture. This provides
better coupling of EM/US field to tissue without distorting
the radiation pattern; at the same time it puts greater de-
mands on reproducible alignment of the applicator relative
to the tumor margin. An adequate bolus design is required
since the dimensions and temperature of the water bolus
significantly affect the applicator power deposition (SAR)
pattern, thermal effective field size (TEFS), and thermal
depth profiles. For EM radiative applicators, the bolus must
be filled with deionized water, whereas for capacitive heat-
ing saline bolus is generally preferred. For US transducers,
the water must be degassed as well. In all cases, the wa-
ter must be circulated through the bolus with a circulation
pump and the temperature controlled within the range of
151 to 45 °C. A bubble trap, impurity filter and a flow in-
dicator is recommended to be included in the circulation
system. The input and output flow connectors of the water
bolus are located on opposite sides. Large applicator arrays
may require dual-input–dual-output ports in order to main-
1 This range includes room temperature as required for QA, in addition
to the 30–45 °C range typical for clinical treatments.
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Fig. 1 Example of the thermal
effective field size (TEFS). Cal-
culated normalized temperature
rise (TR) distribution at 1 cm
depth in a two-layered phan-
tom, with fat layer thickness
of 10 mm overlying the mus-
cle phantom. Heating time t =
6 min, P = 175 W. The black
solid line indicates the appli-
cator aperture, while the black
dashed line represents the water
bolus. The maximum TR in the
1 cm deep plane in muscle-tissue
equivalent phantom is Tmax1cm =
7.6 °C. The TEFS isotherm then
quantifies the area with TR ≥
3.8 °C
tain acceptable temperature homogeneity (<1 °C variation)
across the bolus surface [39–41]. The water bolus can be
filled with low density semirigid porous foam, plastic spac-
ers, or thin rubber pins to avoid collapse of the bolus while
pressed against the skin surface.
Specific features of the water bolus
Some manufacturers provide a water bolus that is an inte-
gral part of the applicator with a rigid plastic frame that
mounts to the applicator aperture [19, 22, 27–29, 33, 35].
While this makes bolus position more reproducible relative
to the applicator, the consequence of a fixed-frame set-up
is often a convex bolus shape with reduced contact area
between water bolus and skin that is smaller than the ra-
diating aperture. This may cause a localized E-field dis-
continuity and associated high tissue temperature rise near
the sharp transition in EM coupling at the water bolus–air
interface if that occurs under a high field region of the ra-
diating aperture [41]. Ultrasound systems require deionized
and degassed water, with the degree of degassing required
inversely proportional to frequency; this is most critical for
systems operating at 0.5–1.5 MHz where a dissolved oxy-
gen content below 0.1 ppm is required to avoid lossy propa-
gation and outgassing of air from the coupling bolus during
ultrasound transmission. In EM capacitive heating systems,
saline (0.1–1.5%) is generally used [43, 44] to improve
impedance matching between electrodes and muscle tissue,
as well as to spread RF currents over the contact area and
thereby reduce skin burns at the edge of the electrode.
Guidelines for proper design and evaluation of the water
bolus
● Size: EM-radiative applicators: the water bolus should
extend at least beyond the perimeter of the applicator
aperture and ideally at least 2–5 cm outside the perime-
ter. Phantom experiments of the applicator with various
bolus sizes are recommended.
EM-capacitive systems: the TEFS is highly dependent on
the size of the contact area of the coupling bolus and tis-
sue. Especially at the edge of the bolus, care must be
taken to provide smooth transitions at the bolus–skin con-
tact at the peripheral rim of the water bolus [42–44].
● Thickness: For EM-radiative applicators the optimal wa-
ter bolus thickness depends on type of applicator, its
dimensions as well as target depth [41] and the thick-
ness should not exceed critical values to avoid oscillation
modes in the bolus layer [45, 46]. These modes occur for
larger sized applicators at frequencies above 100 MHz
[47] and also for suboptimal contact between bolus and
applicator [20].
EM-capacitive systems utilize a frequency below 100 MHz.
They require a minimum water bolus thickness depend-
ing on applicator size to minimize the effect of con-
centrated current at the edge of the metal electrodes.
Their performance is rather insensitive to a variation in
water bolus thickness provided the minimum thickness
requirement is satisfied [43, 44].
For ultrasound applicators with properly degassed water
bolus, thickness has negligible effect on energy propaga-
tion (losses) since the attenuation in water is very low,
but may affect beam pattern shape and position of the
K
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Fig. 2 Example of the thermal effective penetration depth (TEPD). Simulated temperature increase (blue – left axis) and specific absorption rate
(SAR; red – right axis) as a function of depth in the center of two-layered phantom, with fat layer (blue) thickness of 10 mm. Heating time t = 6 min
with P = 175 W and bolus surface temperature identical to the initial phantom temperature. The maximum temperature rise (TR) in the 1 cm deep
plane in muscle-tissue equivalent phantom is Tmax1cm = 7.6 °C. The TEPD is thus the depth where the TR is 3.8 °C, i. e., 39 mm from the tissue
surface. The maximum SAR at 1 cm depth in the muscle is approximately 75%. The resulting effective penetration depth (EPD) derived according
to the traditional definition [7] is indicated by the arrow. Observe that the effective heat penetration is essentially at nearly the same depth for both
definitions
focal zone depending on the device and configuration.
Phantom experiments or direct SAR or intensity mea-
surements must be designed specific for each applicator
with various bolus thicknesses in the clinically relevant
range.
● Variations in bolus thickness (±50%) are inevitable in
clinical conditions due to the irregular skin surface con-
tour. In order to assure that users know how to respond
effectively to patient complaints and to unexpected tem-
perature heterogeneity, the impact of these variations on
field homogeneity and effective field size should be as-
sessed experimentally or by simulations.
● Good contact between bolus and phantom: Wet gauze can
be used to improve heat transfer at the bolus–skin inter-
face for EM devices [41] but proper care must be taken
to ensure that no air gaps occur in the interface [48]. Air
bubbles and air gaps need to be removed with acoustic
gel or water coupling for ultrasound devices.
● The water temperature has a profound impact on the
effective penetration depth: The use of cold water will
increase the effective penetration depth of the maximum
temperature and the therapeutic extent up to 1–2 cm [41,
49]. Experimental evaluation with phantom or pennes
bioheat equation(PBHE)-based models to estimate the
actual penetration depth is therefore recommended for
specific energy modalities and bolus configurations.
These models can also be applied for estimating the
impact of water bolus dimensions and flow.
Characterization of heating properties
Temperature rise criteria for adequate heating
ESHO-TC defines a heating device to be adequate/appropri-
ate if a temperature rise (TR) of at least 6 °C above the start-
ing temperature can be achieved in 6 min at 1 cm depth in
a muscle-tissue equivalent phantom. Devices with heating
depths less than 1 cm that are dedicated to use on lim-
ited depth superficial disease must fulfill the same criterion
at a depth of 0.5 cm. The required temperature increase of
1 °C/min equals a power deposition rate (SAR) of ±60 W/kg
[50].
The thermal effective field size (TEFS) is defined as the
area within the 50% of maximum TR contour (i. e., T ≥
3 °C) in the 1 cm deep plane under the aperture, see Fig. 1.
Similarly, the thermal effective penetration depth (TEPD)
is defined as the depth at which the maximum TR is 50%
of the maximum TR (i. e., T ≥ 3 °C in 6 min) at 1 cm
depth as shown in Fig. 2. Note that the maximum TR at
1 cm depth does not necessarily occur in the central cross
section plane through the applicator as illustrated in Fig. 3.
For consistency, the measurements to determine TEFS
must be made within 15 s after the end of heating to min-
imize thermal conduction smearing of the SAR pattern
within the phantom. If a multi-element applicator array is
used, elements must be arranged such that a continuous
region of TR > 50% of the maximum TR exists. This as-
sessment should be made at a depth of 1 cm. In order to
determine TEPD, analogous measurements at other depths
(>1 cm) are needed until TEPD is found.
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Fig. 3 Calculated normalized specific absorption rate (SAR) distribu-
tion of a 10 × 10 cm lucite cone applicator (LCA) at 1 cm depth in a ho-
mogeneous muscle tissue phantom. The color scale from blue to dark
red represents a 10% SAR increase for every color transition. Adapted
from [66]
Note that besides characterizing the temperature distri-
bution, the efficiency of power transfer within the com-
plete heating system (cables, applicator, and bolus) should
be measured. This information can be used as a reference
value to compare the clinical applied power levels between
hyperthermia centers and assess whether realistic powers
are applied to assure the required increase in tumor temper-
ature. However, it is also important that the user is aware
of how much power is lost in cables, applicator, and bolus.
Efficiency measurements can be accomplished either with
a calorimetric2 method or the total absorbed power may be
calculated from rate of TR measurements.
Note that TR estimation alone is not sufficient for a com-
plete characterization of the system. Numerical modeling
and/or experimental assessment in terms of other param-
eters like SAR are recommended to achieve a more fun-
damental characterization of the system and to assist the
user with determining the relevant parameters for the actual
clinical setup. SAR can be determined with the TR mea-
2 The efficiency of the superficial hyperthermia system is obtained by
calculating the ratio of the EM power absorbed in the phantom to the
net power input to the applicator (forward minus reflected power mea-
sured at the output of the amplifier minus cable losses between ampli-
fier and applicator). The EM power absorbed in the phantom is mea-
sured using the calorimetric method: a well-insulated and well-stirred
liquid muscle-tissue equivalent phantom is heated by the applicator for
10 min with a high EM-power input. The homogeneous temperature
increase of the liquid muscle-tissue equivalent phantom is measured
and total absorbed energy calculated from Pa = ρcpVdT/dt [J/s], in
which Pa is absorbed power, ρ is the density, and cp is the specific heat
capacity of the liquid muscle-tissue equivalent phantom material, V is
the volume, dT the temperature increase, dt is the duration of heating.
surement procedure described above if a short measurement
time of 1 min or less is used to prevent blurring of the SAR
pattern by heat conduction. This will require a sufficiently
high power output to achieve an adequate temperature rise
(e. g., >3 °C) in that short time interval.
The following SAR criteria will then apply for applicator
characterization [7]:
● In these guidelines, we recommend deriving both TEFS
and TEFD from TR measurements. However, the values
derived from SAR, as defined below, may also be useful,
e. g., for comparisons with numerical calculations:
● The effective field size (EFS) is defined by the area within
the 50% of maximum SAR contour in the 1 cm deep
plane under the aperture.
● The effective penetration depth (EPD) is defined by the
depth where the SAR falls to 50% of the maximum SAR
at 1 cm depth. Note that the maximum SAR may not be in
the plane through the main central axes of the applicator.
Generic phantoms
Two models are necessary to characterize heating of two
typical disease conditions: (1) superficial chestwall disease
that extends from the tissue surface to moderate depth (gen-
erally <15 mm), and (1) tumors at moderate depth underly-
ing normal skin and fat.
For reliable phantom measurements the general rule is
that the phantom size should extend beyond the applica-
tor by at least 10 cm in all directions. The thickness of the
phantom should be at least three times the expected pen-
etration depth. Applying this rule leads to the following
recommendations for phantom dimensions:
● Superficial chestwall disease,
– EM-radiative systems: The block phantom should
consist of homogeneous muscle tissue equivalent ma-
terial at least 10 cm thick and extending laterally
10 cm beyond the physical dimensions of the applica-
tor or 5 cm beyond the bolus, whichever is larger.
– EM capacitive systems: The phantom thickness should
be at least 15 cm with lateral dimensions at least twice
as large as the electrodes.
– IR systems: The phantom size should extend beyond
the expected TEFS by at least 5 cm and should have
a thickness of 5 cm.
– US systems: The phantom should consist of homoge-
neous muscle or “soft tissue” equivalent material ex-
tending laterally 5 cm beyond the physical dimensions
of the applicator or the bolus, whichever is larger, and
the thickness should be at least three times the ex-
pected penetration depth.
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Fig. 4 Thermal effective field size (TEFS) profiles should be mea-
sured in three orthogonal planes crossing the center of the applicator
● Tumors at moderate depth underlying normal skin and
fat,
– EM radiative systems: To model tumors underlying
normal fat, a 1 cm thick layer of fat tissue-equivalent
phantom should be placed on top of the muscle phan-
tom which should then have a thickness of at least
9 cm.
– EM capacitive systems: To model tumors underlying
normal fat, a 1 cm thick layer of fat tissue-equivalent
phantom should be placed on top of the muscle phan-
tom which should then have a thickness of at least
14 cm.
– IR systems: Similar to EM phantom with fat layer
thickness of 0.5 and 1 cm.
– US systems: Similar to EM phantom with muscle
phantom thickness at least three times the expected
penetration depth.
In all phantoms, the muscle phantom should be com-
posed of at least two layers separated by a thin (0.1 mm)
polyester, cheesecloth, or mylar film. The US phantoms
should be coupled with liquid or gel, and separated by thin
<50 um polyethylene or mylar film. The thickness of the
upper layer should be 1 cm. For more extensive evaluation
of distributions at different depths in the phantom, the block
of muscle phantom may be separated into additional lay-
ers, with thicknesses of 0.5, 1, 1.5, 2.5 cm in case of EM
devices operating at a frequency of 915 MHz or higher and
1, 1.5, 2.5, 4.5 cm for other frequencies. The fat phantom
should consist of two layers with thickness of 0.5 cm.
If the power deposition pattern will be characterized as
a function of depth with an IR camera, the muscle phan-
tom should be split in two halves along a vertical cross-
section along the center of the phantom. The applicator
should be positioned with its central axis aligned with the
vertical measurement plane of the phantom. The applicator
should be rotated 90° between successive measurements to
determine the pattern along both central (major and minor)
axes of the applicator. A 1 cm thick fat phantom layer split
down the middle should be added to the top of the muscle
phantom to model tumor underlying normal fat.
For all temperature and power deposition measurements,
a proper phantom must be used with the correct electrical,
optical, or ultrasound properties and correct thermal proper-
ties. Tissue equivalence of the phantom material can be ob-
tained by using freshly made materials following a validated
recipe or demonstrating equivalent properties via measure-
ments.
Phantom recipes for electromagnetic equivalent phan-
toms at commonly used frequencies are specified in Ap-
pendix B; a limited set of suggestions of EM–phantom
mixtures for less frequently used frequencies, ultrasound
phantoms, and infrared phantoms are also provided.
Test conditions
The thermal distribution of the applicator should be char-
acterized under standardized operating conditions and at all
frequencies in clinical use. The two generic reference phan-
tom set-ups described in Section Generic phantoms should
be used for this characterization.
All measurements should be carried out at room temper-
ature, i. e., the phantom model should be at equilibrium with
room temperature at the start of each experiment. A bolus
of appropriate dimension should be placed on top of the
phantom with liquid circulating at the same room tempera-
ture as the rest of phantom. The distribution of temperature
rise must be measured in three orthogonal planes crossing
the center of applicator as shown in Fig. 4.
The horizontal plane at 1 cm depth must always be mea-
sured by an IR camera using a horizontally split phantom
with a removable top layer of 1 cm which is removed for
the IR temperature measurement.
The vertical planes (xz, yz) can be measured with one
of three alternative methods as shown in Fig. 5:
a) with IR camera using a vertically split phantom or
b) with IR camera in multiple horizontal planes and post
processing of data from multiple planes,
c) with temperature probes in catheters running through the
phantom at the defined depths. Although this method can
be used, the ESHO-TC prefers the use of methods (a) or
(b) which produce much higher resolution characteriza-
tion of the distribution.
Alternative method (a): Use of a vertically split phantom
is highly recommended for best resolution of TR distribu-
tion.
Alternative method (b): To reconstruct the vertical TR
distribution from multiple horizontal plane data, the mea-
surement planes must include depths of 0.5 (for ≥915 MHz
only), 1, 1.5, 2.5, 4.5 cm and additional depth planes as
needed to measure SAR < 10% of max SAR under the
applicator.
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Fig. 5 Illustration of three al-
ternative options to obtain ther-
mal profile with depth: a thermal
camera view of vertical plane
containing peak temperature rise
(TR); b reconstruction of vertical
distribution from thermal cam-
era views of multiple horizontal
planes; and c multiple measure-
ments along a single axis depth
probe
Alternative method (c): Multiple stationary temperature
probes must be used to obtain a minimum resolution of
1 cm. The absolute TR at each depth measured immediately
after switching on EM, US, or IR power must be used to
plot the temperature depth profile as a means to determine
TEPD.
With any of the methods, if the vertical plane measure-
ments show a deviation of the temperature maximum from
the central plane, an additional measurement must be per-
formed through the vertical plane along the cross-section
of the applicator that includes the true maximum TR. In
addition, at least one temperature sensor must be placed at
1 cm depth in the center of the central plane of the applica-
tor as a reference point regardless of the test set-up applied.
The absolute TR measured at this location is indicative of
the efficiency of the applicator to deposit a high SAR at
this position and combined with applicator input power al-
lows simple quantitative comparison between institutes of
the temperature increase obtained in the fixed 6 min heating
interval. The SAR is related to the temperature increase in
six minutes of heating according the simple formula: SAR
[W/kg] = 67 × dT/dt [°C/min] [50].
Required specifications of the IR thermal imaging
As discussed in method (b), IR thermal imaging is required
for characterization of the temperature distribution in the
horizontal plane at 1 cm depth in phantom. The resolution
of readings and relative accuracy (NETD) of the thermo-
graphic camera should be 0.1 °C and 0.05 °C or better,
respectively. The spatial resolution should be 1–2 mm for
phantoms less than 30 cm2, and 2–3 mm for larger phan-
toms. The camera should be placed at a proper height to
cover the entire phantom surface and test images should be
recorded with rulers in the field of view to ensure correct
rendition of dimensions.
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Appendix A
Detailed description of applicator types with their
advantages and limitations
EM radiative system
For purposes of the present guidelines, radiative applicator
options may be divided into two main types: waveguide
applicators and microstrip applicators.
Waveguide applicators
Waveguide applicators are made from a section of wave-
guide transmission line open at one end with an aperture
of at least a half wavelength in the direction of the E-field.
The excitation is provided by a short extension of the coax-
ial feedline center conductor or a loop antenna inside the
waveguide structure. In order to reduce the physical di-
mensions of the aperture, the applicator may be filled with
a material having a dielectric constant higher than air, such
as Teflon, ceramic, high dielectric powder, or distilled water
[12]. A useful subgroup of waveguide applicators includes
horn applicators that are made by flaring the opening to
spread the radiated field. In one design optimized for use
in an array to heat larger tissue volumes, the lucite cone
applicator provides an effective heating area approximately
2–3 times larger than a conventional waveguide by using
both a dielectric cone in the center of the aperture and
a flared horn configuration with two metal walls of the
waveguide replaced with dielectric to spread the field [17,
18].
● Advantages:
– High ratio of E-field parallel rather than perpendicular
to tissue interfaces such as fat layer.
– Robust applicator with reliable performance.
– Somewhat deeper penetration from nearly plane wave
radiation parallel to the skin surface.
– Spatial control of SAR when used in multi-applicator
configuration.
● Limitations:
– Bulky applicators require stable mounting and posi-
tioning system.
– Rigid shape does not conform to contoured anatomy;
when used in arrays, this limitation is less restrictive.
– Many waveguide structures do not provide heat cover-
age >25% SARmax to the periphery of aperture so may
have regions of tissue <50% SARmax between adjacent
apertures of multi-applicator array.
Microstrip applicators
Microstrip applicators generally consist of printed circuit
metallic patterns on one side of a thin substrate and backed
by a continuous metal ground plane. A water bolus is typ-
ically used to couple the applicator to the contoured tissue
surface and is often mechanically connected to the sidewalls
or back plane of the applicator. Clinically utilized examples
are contact flexible microstrip applicator (CFMA) [19–22,
26, 36], Archimedean spiral applicator [27–29], dual con-
centric conductor (DCC) [30–33], and current sheet appli-
cator (CSA) [25, 34]. Although the radiation patterns from
each aperture differ among the various microstrip designs,
several common attributes can be generalized: thin, low
profile or flexible substrates, small dimensions per radiat-
ing structure, and straightforward combination into multiple
antenna arrays.
● Advantages:
– Lightweight and small size, easy to set up.
– Readily combined into multi-element array applica-
tors.
– Many of the array applicators can conform to con-
toured anatomy.
– Many types have integrated water bolus.
– Comfortable for the patient.
– Spatial control when used in multi-element applicator
configurations with equal number of RF-power gener-
ators.
● Limitations:
– Some have significant electric field component normal
to skin surface and tissue interfaces, which may reduce
the penetration depth substantially.
– Some have power limitations due to potential over-
heating or high reflected power.
EM capacitive systems
EM capacitive heating utilizes two electrodes placed on ei-
ther side of the body to produce superficial hyperthermia
in the proximity of one of the two electrodes [52, 53]. In
order to heat superficial locations, an electrode matching
the lesion size is placed on the target lesion while a larger
electrode that spreads out the current density over a larger
area is situated on the opposite side of the body. The elec-
trodes are connected to an RF power source (8–27 MHz)
and the resulting power deposition pattern is mainly de-
termined by the size and location of the smaller electrode.
Descriptions of the use of EM capacitive heating are given
in [54, 55]. An important factor to consider when applying
EM capacitive heating is to be careful of unintended pref-
erential heating of the high resistance fat tissue layer [56].
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Temperature control of the circulating water in the coupling
bolus is used to address overheating of superficial fat tissue.
● Advantages:
– Easy setup.
– Good penetration depth.
● Limitations:
– No capability for multi-applicator configuration.
– Can overheat fat layer relative to underlying tumor tar-
get.
– Unintended high temperatures at the edge of metal
electrodes if not coupled properly.
US heating systems
Ultrasound heating may be accomplished with round or
square piezoceramic plates or composite transducers, which
create a pressure wave in front of the transducer when ex-
cited at their resonant frequency. The traveling pressure
wave reflects from air so is generally coupled to tissue
with temperature-controlled degassed water and ultrasound
gel to minimize air in the path [57, 58]. Tumor size vol-
umes may be heated by combining multiple transducers in
a nonfocused planar array for superficial heating [59, 60],
or a phased array that creates an intense focal hot spot or
shaped distribution that can be electronically or mechan-
ically scanned at depth to heat a tumor [61–65]. Further
information can be found in a recent review [14].
● Advantages:
– More directional than EM heating, easily focused into
tumor with minimal “sidelobes”.
– Planar array provides more precisely adjustable SAR
patterns that conform to the transducer geometry.
– Thickness of water bolus is mostly irrelevant since de-
gassed water is not lossy.
– Minimal reflections from the edges of water bolus as
long as bolus extends beyond the transducer perimeter.
– Good penetration depth.
● Limitations:
– Preferential absorption of ultrasound in bone and
therefore risk of pain when the tumor is located close
to or overlying bone.
– Reflections and/or absorption of ultrasound at tissue
interfaces with fat, bone, or air/gas (nearly 100%) in-
side the body.
– Must degas the water by vacuum extraction or boiling
to minimize transmission losses through water bolus.
IR devices
IR radiation, also known as thermal radiation, is divided
according to its wavelength into three bands (IR-A, IR-B,
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IR-C). For the longer wavelengths (IR-C), most energy is
absorbed in the skin surface. Therefore the IR-A radiation
associated with wavelengths between 780–1400 nm is use-
ful for heating superficial cancers [15, 67, 68, 70]. Due to
heat dissipation by conduction, convection and Mie-scat-
tering (forward scattering) the primary absorbed radiation
energy is deposited within a larger tissue volume than the
original column of absorption. In order to minimize thermal
exposure of the skin surface, a water filter system must be
integrated with the IR radiation source (wIRA) [15]. The
effective penetration depth of 15 mm has been reported for
such a system [69]. Surface temperatures of T ≥ 42 °C can
be achieved with this heating approach within 5–10 min.
The heating pattern can be shaped using an opaque mask to
block IR radiation at the locations where it is not needed.
● Advantages:
– Heating without contact to patient surface achieves
conformal treatment without potentially painful pa-
tient contact.
– wIRA radiator controlled by noninvasive high-resolu-
tion feedback from thermographic camera adjacent to
radiator.
– Power deposition pattern may be adjusted by plac-
ing shielding sheets under the wIRA radiator to com-
pletely block nontarget tissues.
● Limitations:
– Effective heating depth limited to approximately
15 mm.
– Heating adjustment using 100% blocking sheets is pri-
marily on or off rather than variable heating power ad-
justment across large surface area.
Table B.1 Literature values of relevant dielectric [71, 74], acoustic [72, 74], and thermal properties [74] of muscle and fat
US RF/microwave Physical
2–8 MHz 13.56 MHz 27 MHz 433 MHz 915 MHz
Muscle εr [–] – 138 95.9 56.87 55.00 –
σ [S/m] – 0.628 0.654 0.81 0.95 –
α/f [dB/cm/MHz] 1.1 – – – – –
c [m/s] 1588.4 – – – – –
ρ[kg/m3] – – – – – 1090
cp [J/kg/K] – – – – – 3421
k [W/m/K] – – – – – 0.49
Fat εr [–] – 25.4 18 11.6 11.3 –
σ [S/m] – 0.055 0.06 0.08 0.11 –
α/f [dB/cm/MHz] 0.6 – – – – –
c [m/s] 1440.2 – – – – –
ρ[kg/m3] – – – – – 911
cp [J/kg/K] – – – – – 2348
k [W/m/K] – – – – – 0.21
Where εr [–] is relative dielectric constant, σ [S/m] is electric conductivity, α/f [dB/cm/MHz] is attenuation per frequency, c [m/s] speed of sound,
ρ [kg/m3] is material density, cp is specific heat capacity [J/kg/K], k is thermal conductivity [W/m/K]
Appendix B
Phantom recipes
This appendix identifies recommended phantom mixtures
for muscle and fat tissue equivalent phantoms. The recipes
are given for EM equivalent phantoms at commonly used
frequencies while the US and IR users are referred to spe-
cific reports. Use of other phantom recipes is permitted if
dielectric, acoustic propagation, or optical properties of the
phantom are demonstrated to be equivalent to the muscle/fat
tissues at the frequency of the device under test. The litera-
ture values of the relevant properties of muscle and fat for
commonly used frequencies are summarized in Table B.1
[71–74]. The relevant optical properties, the absorption co-
efficient and reduced scattering coefficients are not stated
in the table, due to their extreme variability with frequency.
Data on the optimal IR frequency band for hyperthermia
purposes are not available presently and therefore IR users
are referred to comprehensive reviews [75, 76].
The list of suggested phantom recipes will be updated
on the ESHO webpage [2].
EM phantoms
Muscle equivalent phantoms
Among numerous recipes for muscle tissue-equivalent
phantoms, two alternative formulas are recommended due
to their appropriate electrical and mechanical properties,
homogeneity, and simplicity of preparation. The ingredients
are listed in Table B.2. The agar phantom originally sug-
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Table B.2 Muscle phantom recipes. The quantities are given for preparation of 1 l of phantom
13 & 27 MHz 433 MHz 915 MHz 433 MHz 915 MHz
Reference [79] Adjusted recipe of [78] Adjusted recipe of [77]
TX 150b/TX 151 (Superstuff) – 19.3 g 18.3 g –
Agar powder 40 g 20.9 g 20.9 g 16 g 16 g
Formaldehyde 8% – 6.7 g 6.7 g – –
NaCl (salt) 2.4 g 3.8 g 4.8 g 10 g 7 g
Deionized Water 956 g 701.6 g 701.6 g 570 g 570 g
Sugar – – 400 g 447 g
Polyethylene powder – 50.1 g 57.6 g –
Permittivity 79.0 60.7 52.8 58.7 52.4
Conductivity S/m 0.44–0.6a 0.85 1.07 0.67 0.98
aThe lower value is recently measured, whereas the higher value is taken from the literature [79]. The difference can be explained by the absence
of highly toxic preservative, NaN3. Hence, it is recommended to use 3.3 g NaCl per liter phantom to achieve an estimated value of 0.6 S/m
bTX 150 & TX 151 (Oil Center Research, Lafayette, LA, USA); * In the original work [70], highly toxic NaN3 was used as preservative. Other,
less toxic preservatives were given with the mass equivalent quantities of NaCl, to compensate the conductivity decrease. Here, the recipe is
adopted for use with formaldehyde 8%. The phantom can be however prepared even without this preservative. In such a case, an equivalent
amount of water should be used.
gested by Nilsson [77] includes NaCl to adjust conductivity
and sugar to provide appropriate permittivity. This phantom
has the advantage of simple preparation that facilitates reli-
able phantom homogeneity. The mechanical strength of the
phantom can be adjusted by the addition of TX-150/1513
gelling powder, also known as Superstuff [78]. Further, the
TX-150/151 increases viscosity and, therefore, allows ad-
dition of polyethylene powder to lower the permittivity to
that of tissue. Both phantoms are relatively easy to prepare,
though the later requires more experienced users to ensure
homogeneity. The lifetime of both phantoms is limited to
a few weeks due to loss of moisture and growth of mold
within the phantom. For phantoms for capacitive systems
a deviation in permittivity is inevitable which justifies se-
lecting the simple agar and NaCl solution phantom. For
a representative electric conductivity it is recommended to
use 3.3 g NaCl per liter phantom, giving an estimated value
of 0.6 S/m.
The agar phantom preparation
1. Dissolve NaCl in deionized water.
2. Add the sugar and heat the solution to around 50–60 °C
in order to dissolve it properly.
3. Add the agar slowly while stirring and heat the mixture
to the boiling point (80–90 °C for about 5 min).
3 TX 150 & TX 151 (Oil Center Research International, L.L.C.,
Lafayette, LA 70503).
* In original work [70], highly toxic NaN3 was used as preserva-
tive. Other, less toxic preservatives were given with the mass equiva-
lent quantities of NaCl, to compensate the conductivity decrease. Here
the recipe is adopted for use with formaldehyde 8%. The phantom can
be, however, prepared even without this preservative. In such a case, an
equivalent amount of water should be used.
4. Pour slowly into the container or mold for cooling and
solidifying. The mixture solidifies at room temperature
within 24 h. Placement of container in cold water bath
will speed up the cooling process.
The superstuff–agar phantom preparation
1. Dissolve NaCl in deionized water.
2. In a separate container, mix the TX-150 (or TX-151) with
the polyethylene powder.
3. Heat the solution of NaCl and deionized water to around
70 °C, and at that point, slowly add the agar while stir-
ring. Continue stirring until the agar is completely dis-
solved. When the mixture is up to 90 °C, remove it from
the heat.
4. When the solution has a temperature of 70–80 °C, add the
mixture of TX-150 (or TX-151) – polyethylene powder
while stirring continuously to ensure homogeneity. Be
careful to avoid generation of air bubbles due to overvig-
orous stirring, as this will reduce phantom homogeneity.
During the process of adding the mixture, keep the tem-
perature of the solution between 70–80 °C. It might be
necessary to turn on/off the heater from time to time.
5. When all the mixture has been added, turn off the heater.
6. If formaldehyde is used to slow the growth of mold, care-
fully add it in this stage.
7. Continue stirring until the phantom partially hardens
which is essential to keep the polyethylene powder uni-
formly mixed.
8. Pour slowly into the container or mold for cooling and
solidifying. The mixture solidifies at room temperature
within 24 h. Placement of the container in cold water bath
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Table B.3 Fat tissue equivalent phantom recipes
13 & 27 MHz 433 MHz 915 MHz 433 MHz 915 MHz
Reference [81] [22, 80] [82]
Laminac 4110 79% 69.30 g 85.2% –
Aluminum powder 20.72% 29.46 g 14.5% –
Shawinigan/Acetylene black 0.28% 0.30 g 0.24% –
XC-72 Carbon powder – 0.94 g – –
MEK peroxide/P 102 resin 7cc/2 kg I part per 200 parts resin 0.375%
Flour – – 500
Oil – – 225
Saline (0.9% NaCl per liter) – – 25
Dielectric constant 19 5.5 5.61 7.1 9.1
Conductivity/S/m 0.028 0.04 0.0665 0.11 0.16
will speed up the cooling process. Experience is nec-
essary to optimize the time of transfer from the mix-
ing container to phantom mold. If poured when the mix-
ture is not sufficiently gelled, the polyethylene powder
will partially separate. If the phantom gets too stiff in
the mixing container, when phantom transferred to the
mold and pushed to fill the corners, large air pockets may
become trapped inside the phantom producing heteroge-
neous phantom properties.
Fat equivalent phantoms
An optimal phantom recipe representing properties of fat
tissue is currently not available. A base formula for good
phantom representing fat tissue in frequency range 10 MHz
to 1 GHz was proposed by Guy et al. [51] and later adapted
by Balzano et al. [81] for 30 MHz. The material consisting
of Laminac 4110 (a polyester resin), acetylene black, and
aluminum powder offers great stability and long shelf life;
nevertheless, it requires relatively complex preparation. An
alternative, easy to prepare formula, proposed by Lagendijk
and Nilson [82], is mixture of flour, oil, and saline water. It
provides homogeneous phantom with appropriate electrical
and mechanical properties; however, the life is relatively
short due to (easy) water evaporation the phantom should
be covered by thin plastic foil and stored in a ‘closed’ envi-
ronment. The phantom was reported for frequency 434 MHz
but can be easily adopted for other frequencies. The recipes
for fat-equivalent phantoms and the corresponding refer-
ences are listed in Table B.3. Yet another option is use of
pig fat, which is easily accessible and has dielectric prop-
erties comparable to human fat.
US phantoms
Muscle phantom
The recommended muscle or “soft tissue” mimicking phan-
tom for acoustic and thermal testing of ultrasound thermal
therapy devices was developed recently by investigators at
the US Food and Drug Administration [83]. This nontoxic
formulation has thermal conductivity, acoustic attenuation,
and acoustic impedance similar to soft tissue. The recipe
utilizes a gellan gum as gelling agent with melting tem-
perature above 100 °C, calcium chloride dehydrate to en-
hance the gel strength and potassium sorbate which acts
as preservative. The ultrasound attenuation is simulated by
using different sizes of aluminum oxide particles, while
the acoustic velocity is adjusted by isopropanol. The pro-
tocol and complete recipe can be found in the literature
[84]. The attenuation coefficient has essentially linear fre-
quency dependence, as is the case for most mammalian tis-
sues at 37 °C. The mean value of attenuation coefficient is
0.64*f0.95 dB cm–1 at 20 °C in the measured frequency range
from 2 to 8 MHz. When using low frequency ultrasound
sources, penetration through the phantom can be high so
the thickness of phantom model needs to be sufficient to
fully absorb the energy prior to reflections off the bot-
tom of phantom. Alternatively, an absorber such as a soft
20–30 durometer rubber can be added as a back layer to
minimize reflections.
Fat phantom
A fat-mimicking phantom in which oil droplets are dis-
persed in a water-based gelatin [85] is recommended. The
phantom has appropriate ultrasonic parameters for fat, such
as lower density, speed of sound, and an attenuation coeffi-
cient that is nearly proportional to the frequency. The only
drawback is the somewhat complex preparation procedure
described in [85]. In some cases with split phantoms, where
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Table C.1 Routine quality assurance procedures
Interval Daily Quarterly
3 months
6–12 months
Topic Visual check Acceptance
criterion
Check func-
tion
Acceptance crite-
rion
Check function Acceptance crite-
rion
Temperature
probes
Broken probes Accuracy
±0.2 °C
Full range
calibration
Accuracy ±0.2 °C
over 37–45 °C
– –
Water bolus Leakage, intact
structure
Good circula-
tion
– – – –
Water system Tubing and
connections
Good circula-
tion
Water ex-
change
Correct electrical
conductivity
– –
Power system Damage Power output
as expected
– – Full calibration,
power output
Power reading
forward and re-
flected ±5%
Applicators Damage SAR pattern
as expected
– – Heating pattern TEFS, TEFD,
EFS, efficiency
Control system Interaction of
commands
Proper func-
tioning con-
trol algorithm
Back-up
system
Proper function Update software Verify system
performance
Safety Cable connec-
tions
Correct un-
damaged
connections
– – Stray radiation Values within
EU/FCC regula-
tions
the temperature index (TEFS or SAR) is measured in the
deeper solid soft tissue layer, it may be possible to use
a suspension of pure safflower oil and polyurethane mesh
within a shaped bag and of appropriate thickness to mimic
the acoustic impedance and penetration characteristics of
an intervening layer of fat [86].
IR phantoms
Due to the extreme variability of dielectric properties over
the IR frequency spectrum, it is only possible to define
phantoms for very specific portions of the spectrum. IR
users are, therefore, referred to a recent review [87] which
discuss the benefits and weaknesses of various recipes
(for optical spectroscopy, imaging and dosimetry) in terms
of gelling agents and materials that mimic scattering and
absorption. Two alternative compositions can be recom-
mended: (1) The agar phantom with Intralipid™ acting as
a scattering medium, and India ink acting as an absorbing
medium [88]. Note that agar might affect the optical prop-
erties and therefore only highly purified powder can be
used. (2) A silicon-based phantom [89] whose absorption
and scattering properties are adjusted by adding matrix
cosmetic powder and Al2O3 particles to the silicone base.
This phantom exhibits good macroscopic homogeneity can
be cast into layers or arbitrary shapes with long shelf life.
Appendix C
Routine QA for superficial microwave hyperthermia
system
During routine use, a deterioration of applicator perfor-
mance could occur. It is typically indicated by a sudden
change in the power required to achieve the desired temper-
ature. The operator should be continuously alert for such
changes. As part of a clinical quality assurance program,
general QA routines common to most hyperthermia sys-
tems are specified in Table C.1. These should be performed
at regular intervals as a part of the clinical QA program.
System specific QA procedures given by manufacturers/
suppliers will be available on the ESHO website [2].
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